Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines

Authors

Romaana Mir, Mount Vernon Cancer Centre
Jeff M Michalski, Washington University School of Medicine in St. Louis
et al.

Journal

Radiotherapy and Oncology

Publication Date

9-1-2020

Volume

150

First Page

30

Last Page

39

Document Type

Open Access Publication

DOI

10.1016/j.radonc.2020.05.038

Rights and Permissions

Mir R, Kelly SM, Xiao Y, Moore A, Clark CH, Clementel E, Corning C, Ebert M, Hoskin P, Hurkmans CW, Ishikura S, Kristensen I, Kry SF, Lehmann J, Michalski JM, Monti AF, Nakamura M, Thompson K, Yang H, Zubizarreta E, Andratschke N, Miles E. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. Radiother Oncol. 2020 Sep;150:30-39. doi: 10.1016/j.radonc.2020.05.038 Copyright 2020 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Mir, Romaana; Michalski, Jeff M; and et al., "Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines." Radiotherapy and Oncology. 150, 30 - 39. (2020).
https://digitalcommons.wustl.edu/oa_4/575